Cimicoxib
Alternative Names: UR 8880Latest Information Update: 15 Aug 2013
At a glance
- Originator Uriach
- Developer Affectis Pharmaceuticals
- Class Anti-inflammatories; Antirheumatics; Imidazoles; Non-opioid analgesics; Sulfonamides
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 15 Aug 2013 No development reported - Phase-II for Major depressive disorder in Austria (PO)
- 15 Aug 2013 No development reported - Phase-II for Major depressive disorder in Czech Republic (PO)
- 15 Aug 2013 No development reported - Phase-II for Major depressive disorder in Germany (PO)